6191 related articles for article (PubMed ID: 2417097)
21. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
22. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
23. Immunological aspects of experimental brain tumors (review).
Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy for glioma: promises and challenges.
Han SJ; Zygourakis C; Lim M; Parsa AT
Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649
[TBL] [Abstract][Full Text] [Related]
25. Adoptive immunotherapy of CNS malignancies.
Plautz GE; Shu S
Cancer Chemother Biol Response Modif; 2001; 19():327-38. PubMed ID: 11686021
[TBL] [Abstract][Full Text] [Related]
26. Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
Mitra S; Li G; Harsh GR
Neurosurg Clin N Am; 2010 Jan; 21(1):67-76. PubMed ID: 19944967
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 2-activated cytotoxic lymphocytes in cancer therapy.
Grimm EA; Jacobs SK; Lanza LA; Melin G; Roth JA; Wilson DJ
Symp Fundam Cancer Res; 1986; 38():209-19. PubMed ID: 3489259
[TBL] [Abstract][Full Text] [Related]
28. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
29. [Monoclonal antibodies against human brain tumors].
Yoshida J
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1706-14. PubMed ID: 6347088
[TBL] [Abstract][Full Text] [Related]
30. Biologic and immune modulating agents in the treatment of childhood brain tumors.
Packer RJ; Kramer ED; Ryan JA
Neurol Clin; 1991 May; 9(2):405-22. PubMed ID: 1944107
[TBL] [Abstract][Full Text] [Related]
31. Immunobiology of brain tumors.
Frank E; de Tribolet N
Neurosurg Rev; 1986; 9(1-2):31-7. PubMed ID: 3090477
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer vaccines: current status.
Hwang LC; Fein S; Levitsky H; Nelson WG
Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
[TBL] [Abstract][Full Text] [Related]
33. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
Yu JS; Luptrawan A; Black KL; Liu G
Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of brain tumors.
Mahaley MS
Semin Oncol; 1975 Mar; 2(1):75-8. PubMed ID: 1234797
[TBL] [Abstract][Full Text] [Related]
35. [Cellular immunotherapy for malignant glioma].
Okamoto Y; Yamashita J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
[No Abstract] [Full Text] [Related]
36. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
Liu A; Hu P; Khawli LA; Epstein AL
J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
[TBL] [Abstract][Full Text] [Related]
37. Antibodies in the therapy of colon cancer.
Welt S; Ritter G
Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
[TBL] [Abstract][Full Text] [Related]
38. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
39. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
40. [Advances of BRM therapy of malignant brain tumors].
Nagai M
Gan To Kagaku Ryoho; 1991 Feb; 18(2):188-94. PubMed ID: 1992912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
